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http://dx.doi.org/10.1016/j.kjms.201Abstract Inhibiting the healing of wounds to ensure that the aqueous humor can drain into
the scleral space unimpeded and form a filtering bleb plays a crucial role in determining the
success rate of glaucoma surgery. The aim of this study was to investigate the novel use, with
cell culture and animal models, of some commercial intraocular pressure (IOP)-lowering drugs
in inhibiting the healing of fibroblast wounds. The Tenon’s fibroblasts of rabbits were cultured
to evaluate 13 IOP-lowering drugs for cellular proliferation, collagen formation, and migration.
These were measured using [3H]thymidine and [3H]proline uptake, and Transwell chambers. A
preservative of benzalkonium chloride (BAK) was initially used, with 0.02% as a maximal orig-
inal concentration. All of the drugs and the BAK were diluted from original commercial concen-
trations to 1/10, 1/100, and 1/1000. The more inhibitive drugs screened from the cell cultures
were then selected for further short-term application during and after trabeculectomy
surgeries had been performed on the rabbits. Expression of the proliferative cell nuclear
antigen was immunohistochemically examined 3 and 7 days after surgery. The results revealed
that the inhibitive effects of BAK in cellular [3H]thymidine and [3H]proline uptake, and cellular
migration were only evident at 0.002% concentrations. Based on the results of the cell
cultures, timolol, latanoprost, and unoprostone exhibited a greater inhibitory effect thanf Pharmacology, Department of Pharmacology, College of Medicine, Kaohsiung Medical University,
Taiwan.
.tw (S.-J. Hong).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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354 K.-Y. Wu et al.the other drugs. Moreover, the animal studies showed that latanoprost and unoprostone signif-
icantly suppressed the positive expression of proliferative cell nuclear antigen around the
operative excision area 7 days after the trabeculectomy surgeries. The results indicate that
short-term use of some IOP-lowering drugs, such as latanoprost and unoprostone, may inhibit
postoperative wound healing after glaucoma surgery.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Glaucoma is one of the leading causes of permanent blind-
ness. Trabeculectomy, a filtering surgery for glaucoma, is
currently the most frequently performed surgical procedure
in the treatment of this disease [1,2]. The surgery creates
a block excision into the anterior chamber from under
a partial-thickness scleral flap to form a filtering bleb.
Aqueous humor flows through that passage from the anterior
chamber to the subconjunctival space, to decrease the
intraocular pressure (IOP). However, the prognosis and
success rates for glaucoma surgery are largely dependent on
wound healing and adhesion. Exaggerated wound healing,
especially around the operative excision area, always
results in the closure of the passage between the anterior
chamber and the subconjunctival space therefore it leads to
an obstruction of the outflow of aqueous humor and reduces
the prognosis for surgical success [3].
The wound-healing process is a complex mechanism that
involves proliferation at the wound site, cellular migration
to the wound, and synthesis of new extracellular matrix
components [4]. Studies have revealed that wound healing
after glaucoma surgery consists mainly of fibroblast prolif-
eration within the first 2 days and an increase in collagen
components over time [5]. Some antineoplastic drugs have
therefore been used to interfere with early postoperative
fibroblast proliferation to prevent closure of the filtration
fistula [6]. Many reports have, however, demonstrated that
antineoplastic drugs are rather toxic to ocular tissues and
cause many side effects, such as a high incidence of thin
blebs, persistent hypotony, and choroidal detachment after
trabeculectomy [7e9].
Studies have also shown that many IOP-lowering drugs
have potent effects in inhibiting cellular proliferation in
cultured Tenon’s fibroblasts [10,11]. Moreover, some IOP-
lowering drugs, such as latanoprost and unoprostone,
reduce the release of extracellular matrix production by
Tenon’s capsule fibroblasts and modulate collagen turnover
[12,13]. These effects may interfere with the early stage of
wound healing after filtering surgery.
In the present study, we investigated the effects of
several IOP-lowering drugs on the inhibition of wound heal-
ing, using cell culture and animal models. Initially, cultured
Tenon’s fibroblasts were used to screen the more inhibitive
drugs in cellular proliferation, migration, and collagen
synthesis. In the second step, the drugs that were selected
from the cell culture were applied to the trabeculectomy
wound area in rabbits. Finally, the PCNA numbers around the
operative excision area after trabeculectomy surgery was
immunohistochemically examined in order to select the best
drug for wound healing inhibition.Methods
Drugs preparation
Commercial IOP-lowering drugs including 0.5% levobunolol
[Bunolgan, Allergan, 0.004% benzalkonium chloride (BAK)],
0.25% timolol (Timoptol, Merck Sharp & Dohme-Chibret,
0.0048% BAK), 0.03% bimatoprost (Lumigan, Allergan,
0.005% BAK), 0.004% travoprost (Travatan, Alcon, 0.015%
BAK), 0.005% latanoprost (Xalatan, Pharmacia & Upjohn,
0.02% BAK), 0.12% isopropyl unoprostone (Rescula, Fujisawa,
0.015% BAK), 1% carteolol (Arteoptic, Otsuka, 0.005% BAK),
0.5% betaxolol (Betoptic, Alcon, 0.01% BAK), 1% brinzola-
mide (Azopt, Alcon, 0.01% BAK), 2% dorzolamide (Trusopt,
Merck Sharp & Dohme-Chibret, 0.0075% BAK), 0.2% brimo-
nidine (Alphagan, Allergan, 0.001% BAK), 1% pilocarpine
(Spersacarpine, Dispersa, 0.01% BAK) and 0.1% dipivefrin
(Propine, Allergan, 0.004% BAK)were available for this study.
The BAK and diaminobenzidine were purchased from Sigma
Chemical (St. Louis, MO, USA). All other chemicals were
obtained from Merck (Darmstadt, Germany).
Culture of rabbit Tenon’s fibroblasts
Rabbit Tenon’s capsule fibroblast tissue cultures were
established according to the procedure described previ-
ously [11]. New Zealand albino rabbits were euthanized
with ketamine (Parke-Davis, Ketalar, Pfizer). Dissection was
performed under sterile conditions in a laminar-flow hood.
The ocular Tenon’s tissues were removed and minced into
1-mm cubes and plated in a culture flask. The culture
medium, which contained RPMI-1640 (GIBCO, Grand Island,
NY, USA) supplemented with 10% fetal bovine serum
(GIBCO), 3.8mM L-glutamine (GIBCO) and 50 mg/mL genta-
micin (GIBCO), was placed over the tissues. The tissues
were cultured in a humidified 5% CO2 incubator at 37
C.
Fibroblasts usually appeared within 3e7 days. The cells
used in this experiment were passage three to passage six.
[3H]thymidine and [3H]proline uptake
To estimate cellular proliferation and the rate of collagen
formation, the uptake of [3H]thymidine and [3H]proline into
cultured cells was measured following previously published
procedures [14]. Cultured Tenon’s fibroblasts were plated
onto 12-well plates for at least 24 hours to allow for
attachment. Cultured cells were incubated with serum-free
RPMI-1640 medium containing various concentrations
of drugs diluted from original commercial concentrations to
1/10, 1/100, and 1/1000 for 20 minutes at 37C. Following
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a fresh culture medium. Then, 1 mCi/mL of [3H]thymidine
(specific activity 15.0 Ci/mmol; New England Nuclear, Du
Pont, Boston, MA, USA) or [3H]proline (specific activity
112.0 Ci/mmol; New England Nuclear) was separately
added into wells for 4 hours incubation, then uptake assays
were stopped by rapid washing with ice-cold phosphate-
buffered saline (PBS). The cells were lysed in 2% sodium
dodecyl sulfate prior to quantification of radioactivity for
[3H]thymidine uptake. In the case of [3H]proline uptake,
cells were lysed in 2% sodium dodecyl sulfate and proteins
were precipitated with 10% trichloroacetic acid. Precipi-
tate was collected by filtration under vacuum onto glass
fiber disks, which were washed twice with ice-cold 5% tri-
chloroacetic acid and 100% ethanol, respectively. Radio-
activity on the disks was measured by scintillation counting
(Tri-Carb 2100TR Liquid Scintillation Counter, USA).
Cell migration
Cell migration was measured following previously published
procedures [14]. Cells were seeded into the upper cham-
bers of 12-well Transwell plates with 12-mm pores (Costar,
Cambridge, MA, USA), allowing at least 24 hours for
attachment. Cells in the upper chamber were incubated
with serum-free RPMI-1640 medium containing various
concentrations of drugs diluted from original commercial
concentrations to 1/10, 1/100, and 1/1000 for 20 minutes
at 37C. The medium in the upper chamber was then
removed and fresh serum-free medium was added to the
upper and lower chambers. The assembled chambers were
then incubated for 24 hours to allow the cells to migrate
through the pores of the filter membrane. The filter and
lower chamber were then fixed with formalin, stained with
hematoxylin and air-dried. A microphotograph was taken at
the focus level of the lower surface of the filter membrane
and the lower chamber plate. Cell migration was measured
by counting the number of spreading cells. Cells whose
nuclei were present in the pores of the membrane were
excluded.
Trabeculectomy in rabbits
The trabeculectomy experiment in rabbits was approved by
the Institutional Animal Care and Use Committee of Kaoh-
siung Medical University. The trabeculectomies were per-
formed by the same surgeon, according to the procedure
described previously [15]. New Zealand albino rabbits,
weighing 2.5e3.0 kg, were assigned to five groups: negative
control (serum-free medium), 0.02% BAK diluted with
serum-free medium, timolol, latanoprost, and unoprostone
treatments. Each group consisted of 12 rabbits. All rabbits
were anesthetized by intramuscular injection of 35 mg/kg
ketamine and 5 mg/kg xylazine, and trabeculectomies were
performed on their eyes (12 eyes of 12 rabbits). After
creating a fornix-based conjunctival incision, a half-
thickness scleral flap 3e4 mm wide was dissected into the
clear cornea. Each group was administered a 25-mL solu-
tion, which was sterilized with a 0.2-mm filter in advance,
administered under the scleral flap for 10 minutes. Then,
a trapezoid block excision (about 1.5  2 mm) was createdat the area to spur. Finally, the scleral flap and conjunctival
wound were closed by suturing with 10-0 nylon. After the
trabeculectomies, the respective solutions were adminis-
tered topically, four times daily, on each surgical eye.
Without any antibiotic or corticosteroid eye-drop applica-
tion, the rabbits were euthanized, some on day 3 after the
filtering surgery and some on day 7, with ketamine for
histological and immunohistological examinations.
Histological preparation
The rabbits were histologically studied to examine the
effects of various solutions on the inhibition of post-
operative wound healing. At 3 and 7 days after surgery,
six rabbits in each group were euthanized with ketamine.
The eyeballs (6 eyes of 6 rabbits) were then nucleated and
fixed in 3% cacodylate buffer overnight. The specimens
were taken from the conjunctiva/Tenon’s capsule incision
containing the sclerostomy and suture areas for each
eyeball. The segments were then dehydrated through
a graded alcohol series and embedded in paraffin. Sections
were vertically cut, with an operative excision area of 6 mm
thickness, mounted on slides, and dried for histological
staining. After removing the paraffin with CitriSolv solution
and rehydration through a serial ethanol grade, one slice
with an approximately maximal area in the operative
excision area was selected for hematoxylineeosin staining.
Then, moving forward and backward, three more serial
slices from each rabbit were selected for further immuno-
histochemical staining.
Immunohistochemical staining of proliferating cell
nuclear antigen
Immunohistochemical staining was performed according to
our previously published method [14]. Paraffin-embedded
sections were de-paraffinized in CitriSolv solution and
rehydrated through a graded alcohol series. Endogenous
peroxidase activity was quenched by immersing the speci-
mens in 2% H2O2 at room temperature for 5 minutes. The
non-specific blots were blocked at room temperature for
10 minutes in PBS containing 5% normal goat serum.
Sections were washed with PBS and rinsed with 0C acetone
for 20 seconds. Following a PBS washing, a biotinylated
mouse antiproliferating cell nuclear antigen (PCNA) primary
antibody (1:120; Zymed, San Francisco, CA, USA) was
applied to the tissue in a humidified chamber at 37C for 1
hour. After washing with PBS, tissues were further incu-
bated with streptavidinehorseradish peroxidase (1:1000,
Zymed) for 20 minutes at room temperature. The sections
were then immersed in 0.2 mg/mL diaminobenzidine solu-
tion at room temperature for 5e10 minutes until a satis-
factory color reaction was achieved. A qualitative analysis
of the PCNA numbers around operative excision area was
counted using Nikon light microscopy connected to a high-
resolution television monitor.
Statistical analysis
Statistical analysis was performed for the cell culture and
animal experiments by one-way analysis of variance,
Figure 1. Dose-dependent curves of the IOP-lowering drugs
and benzalkonium chloride (BAK) on cellular [3H]thymidine
uptakes in cultured Tenon’s fibroblasts. Cells were exposed to
various drugs, which were diluted to 1/10, 1/100, and 1/1000
from original concentrations. BAK was initially used with 0.02%
as a maximal original concentration. The values from all the
IOP-lowering drugs, diluted to 1/10, 1/100, and 1/1000
concentrations, were compared with BAK results at 0.002%,
0.0002%, and 0.00002%, respectively. The values were signifi-
cantly different from corresponding BAK diluted group at
p < 0.05.
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mean  standard deviation. In the cellular experiments, all
data are presented as percentages of negative control,
which was assumed as 100% response, and were collected
from three experiments with triplicate determinations. The
values from all the IOP-lowering drugs, diluted to 1/10, 1/
100, and 1/1000 concentrations, were compared with BAK
results at 0.002%, 0.0002%, and 0.00002%, respectively. In
the animal study, the data were collected from six rabbits,
with an average of six sections from each rabbit. The values
were considered significant at p < 0.05.
Results
Effects of benzalkonium chloride
In the cellular study, only 0.002% BAK, which was regarded
as the 1/10 group, caused a cytotoxic effect in [3H]thymi-
dine, proline uptake, and migration. BAK at 0.0002% and
0.00002% exhibited no significant toxic effects compared
with the negative control value. In order to eliminate the
potentially toxic effect of BAK in the drugs tested, the 1/10
diluted values of all the IOP-lowering drugs were compared
with the result of 0.002% BAK, which was regarded as the 1/
10 group. In the case of 1/100 and 1/1000, the diluted
values of all drugs tested were compared with the 0.0002%
and 0.00002% BAK values, respectively.
The effects of drugs on cellular [3H]thymidine
uptake
To estimate the effects of the IOP-lowering drugs, including
betaxolol, timolol, bimatoprost, travoprost, latanoprost,
unoprostone, carteolol, levobunolol, brinzolamide, dorzo-
lamide, brimonidine, pilocarpine, dipivefrin, and BAK on
cellular proliferation, [3H]thymidine uptake was performed
in the cultured cells. The effects of the IOP-lowering drugs
on cellular proliferation are shown in Fig. 1. In all the drugs
tested, the 1/10 diluted concentrations significantly
inhibited [3H]thymidine uptake compared with the negative
controls, which were assumed to have 100% response. In
the presence of 1/10 diluted concentrations of the various
drugs, the cellular proliferation was reduced to 64%  3% by
0.002% BAK, 54%  2% by betaxolol, 51%  2% by timolol,
60%  2% by bimatoprost, 59%  3% by travoprost, 34%  1%
by latanoprost, 11%  1% by unoprostone, 65%  2% by
carteolol, 63%  2% by levobunolol, 61%  3% by brinzola-
mide, 59%  3% by dorzolamide, 65%  3% by brimonidine,
66%  2% by pilocarpine, and 59%  2% by dipivefrin,
compared to the value of 15,308  459 (DPM/mg total
protein), which was assumed as a 100% response (Fig. 1A
and B). Only betaxolol, timolol, latanoprost, and unopro-
stone at 1/10 diluted concentrations showed a significant
decrease compared with the 0.002% BAK value, which was
regarded as the 1/10 group.
Most of the IOP-lowering drugs at 1/100 and 1/1000
dilutions did not significantly decrease cellular [3H]thymi-
dine uptake, except for betaxolol, timolol, latanoprost,
and unoprostone. The 1/100 diluted concentrations of
betaxolol, timolol, latanoprost, and unoprostone inhibited
cellular [3H]thymidine to 85%  2%, 82%  3%, 65%  2%,and 34%  2%, respectively, compared with 0.0002% BAK,
which had a value of 99%  2% (Fig. 1A). Moreover, only the
1/1000 diluted concentrations of latanoprost and unopro-
stone significantly inhibited cellular [3H]thymidine to
81%  2% and 64%  2%, respectively, compared with
0.00002% BAK, which had a value of 100%  2% (Fig. 1A).
The effects of drugs on cellular [3H]proline uptake
To investigate collagen production, [3H]proline uptake was
performed in the cultured cells. The [3H]proline uptake
results were similar to the [3H]thymidine uptake results. The
1/10 tested drugs significantly inhibited [3H]proline uptake
compared with the negative control, which was assumed as
100% response. The cellular [3H]proline uptake for 0.002%
BAKwas reduced to 82% 3%,whichwas regardedas the 1/10
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10 concentrations significantly inhibited [3H]proline uptake
compared with the negative control. At 1/10 diluted
concentrations, only betaxolol, timolol, latanoprost, and
unoprostone significantly decreased the 0.002% BAK value,
which was regarded as the 1/10 group. In the presence of 1/
10 diluted concentrations of the various drugs, cellular
collagen production was reduced to 47%  2% by betaxolol,
32%  1% by timolol, 80%  2% by bimatoprost, 77%  3% by
travoprost, 14% 1%by latanoprost, 9% 1%byunoprostone,
82% 3% by carteolol, 82% 3% by levobunolol, 77% 2% by
brinzolamide, 79%  3% by dorzolamide, 78%  3% by bri-
monidine, 76%  3% by pilocarpine, and 80%  2% by dipive-
frin, compared with the negative control value of 4607 184
(DPM/mg total protein), which was assumed as 100%
response (Fig. 2A and B). Most of the IOP-lowering drugs at 1/
100 and 1/1000 dilutions did not decrease cellular [3H]
proline uptake, except for betaxolol, timolol, latanoprost,Figure 2. Dose-dependent curves of the IOP-lowering drugs
and benzalkonium chloride (BAK) on cellular [3H]proline
uptakes on cultured Tenon’s fibroblasts. Cells were exposed to
various drugs, which were diluted to 1/10, 1/100, and 1/1000
from original concentrations. BAK was initially used with 0.02%
as a maximal original concentration. The values from all the
IOP-lowering drugs, diluted to 1/10, 1/100, and 1/1000
concentrations, were compared with BAK results at 0.002%,
0.0002%, and 0.00002%, respectively. The values were signifi-
cantly different from corresponding BAK diluted group at
p < 0.05.and unoprostone, compared with the respective BAK values.
The 1/100 diluted concentrations of betaxolol, timolol,
latanoprost and unoprostone significantly inhibited cellular
[3H]proline to 85%  3%, 80%  2%, 55%  2% ,and 39%  2%,
respectively, compared with the 0.0002% BAK value of
100%  2% (Fig. 2A). Only 1/1000 diluted concentrations of
latanoprost and unoprostone significantly inhibited cellular
[3H]thymidine to 78%  3% and 70%  2% compared with the
0.0002% BAK value of 100%  3% (Fig. 2A).
The effects of drugs on cellular migration
The dose-response curves of the drugs tested are shown in
Fig. 3 for cellular migration. The results of cell migration
were similar to [3H]thymidine and [3H]proline uptake,
except for betaxolol. In the case of 0.002% BAK, which was
regarded in the 1/10 group, cellular migration wasFigure 3. Dose-dependent curves of the IOP-lowering drugs
and benzalkonium chloride (BAK) on cellular migration in
cultured Tenon’s fibroblasts. Cells were exposed to various
drugs, which were diluted to 1/10, 1/100, and 1/1000 from
original concentrations. BAK was used with 0.02% as a maximal
original concentration. The values from all the IOP-lowering
drugs, diluted to 1/10, 1/100, and 1/1000 concentrations,
were compared with BAK results at 0.002%, 0.0002%, and
0.00002%, respectively. The values were significantly different
from the corresponding BAK-diluted group at p < 0.05.
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control value of 100% response. Most drugs exhibited no
significant difference at 1/10 diluted concentrations
compared with the 0.002% BAK value. The effect was
inhibited to 73%  2% by betaxolol, 73%  2% by bimato-
prost, 70%  3% by travoprost, 71%  2% by carteolol,
74%  3% by levobunolol, 77%  3% by brinzolamide,
69%  2% by dorzolamide, 78%  2% by brimonidine,
71%  1% by pilocarpine, and 79%  2% by dipivefrin (Fig. 3A
and B).
Of all the drugs tested at 1/10 and 1/100 diluted
concentrations, cellular migrations were only inhibited by
timolol (to 53%  3% and 68  2%), by latanoprost (to
45%  2% and 59%  3%), and by unoprostone (to 33%  2%
and 53%  2%), respectively (Fig. 3A). Using the data from
the cell cultures, we selected the three most effective
drugsdtimolol, latanoprost, and unoprostonedto be
tested in the animal study.The effects of drugs on proliferating cell nuclear
antigen numbers after trabeculectomy in rabbits
The positive PCNA numbers were counted around the
operative excision wound area in the five groups, which
included negative control with serum-free medium, 0.02%
BAK diluted with serum-free medium, timolol, latanoprost,
and unoprostone groups 3 and 7 days after trabeculectomy
in the rabbits. Three days after surgery, immunohisto-
chemical staining of PCNA cells revealed that three
drugsdtimolol, latanoprost, and unoprostonedstatistically
decreased the numbers of PCNAs around the operativeFigure 4. Numbers of proliferating cell nuclear antigen
(PCNA) immunopositive cells around trapezoidal excision
wound areas 3 and 7 days after trabeculectomy in rabbits. The
cells were counted in the control (Con), 0.02% benzalkonium
chloride (BAK), timolol (Tim), latanoprost (Lat) and unopro-
stone (Uno) groups. The data were collected from six rabbits,
with an average of six sections from each rabbit. The values
were significantly different from corresponding control group
at p < 0.05.excision wound area compared with the control group
(Fig. 4). The number PCNA cells with positive staining were
209  31, 132  17, 83  8, and 34  9 for 0.02% BAK,
timolol, latanoprost, and unoprostone, respectively,
compared with the negative control of 216  26.
Seven days after surgery, the 0.02% BAK and timolol
groups exhibited no significant differences from the control
group, with PCNA counts of 2698  289 and 2348  238,
respectively. Only latanoprost and unoprostone statistically
decreased the positive immunohistochemical PCNA
numbersd427  56 (latanoprost) and 216  43
(unoprostone)dcompared with the control number of
2827  248. The typical morphological characteristics of
hematoxylin and eosin staining (Fig. 5A, C and E) and
immunopositive staining of PCNA cells (Fig. 5B, D and F) in
the negative control and latanoprost- and unoprostone-
treated sections 7 days after surgery are shown in Fig. 5.
In the control eyes that underwent trabeculectomy, the
number of immunoreactive PCNA cells increased after
surgery. Seven days after surgery, in the control section,
the hole created by the operative excision was almost
obstructed and the PCNA cells had built up in the
surrounding wound area (Fig. 5B). However, the numbers of
immunoreactive cells in the latanoprost (Fig. 5D) and
unoprostone-treated sections (Fig. 5F) were much lower
than in the control section (Fig. 5B).Discussion
In the present study, we determined whether the short-
term application of some IOP-lowering drugs, such as
latanoprost and unoprostone, could be utilized as wound-
healing inhibitors to retard wound occlusion after glau-
coma surgery. Until now, many commercial IOP-lowering
drugs have been applied in the treatment of glaucoma.
After glaucoma filtration surgery, IOP-lowering drugs are
usually withdrawn, as the IOP has been decreased by the
fistula that has been created. Even when IOP-lowering
drugs are administered for a few days after surgery, they
do not necessarily maintain bleb formation. Therefore,
whether or not the IOP-lowering drug interferes the
wound healing may be a matter of concern. In the present
study, it was demonstrated that with short-term admin-
istration of latanoprost or unoprostone for a few days
after filtering surgery, the wound area, especially the
fistula entrance, may be maintained postoperatively for
a longer period of time than without using an IOP-lowering
drug.
When IOP-lowering drugs are introduced as a wound-
healing inhibitor, the best time for the drug’s application to
inhibit extracellular matrix formation, cell migration, and
fibroblast proliferation is during and after the operation.
Wound healing in cellular proliferation after glaucoma
filtering surgery happens as early as 24 hours post-
operatively, and peak proliferation is during the first 5 days
postoperatively [16]. Studies also have revealed that
collagen is promptly enhanced during the first 7 days after
filtering surgery [17]. Examination of PCNA, which is used as
a marker of cell proliferation after filtration surgery, yields
similar results in rabbit eyes [18]. Based on the data from
our animal experiments, the number of immunoreactive
Figure 5. The typical morphological characteristics of hematoxylin and eosin staining and immunopositive staining of PCNA cells
in the control and latanoprost- and unoprostone-treated sections 7 days after surgery in the rabbits. (A, C, E) Specimens were
stained with hematoxylineeosin (original magnification  100) and (B, D, F) mouse anti-PCNA primary antibody (original
magnification  400) in the control (Con, A, B), latanoprost (Lat, C, D) and unoprostone (Uno, E, F) groups. Arrows indicate the
trapezoidal excision wound areas.
Intraocular drugs as wound-healing inhibitors 359PCNA cells in the control eyes promptly increased from
three to seven after surgery, and the filtering site was
almost completely obstructed by the 7th postoperative day.
Thus, the critical time to inhibit wound healing is within the
1st week after filtering surgery.
The wound-healing process involves the production of
extracellular matrix components such as collagen and
cellular migration [4,19]. Based on the data from the cell
culture, timolol, latanoprost, and unoprostone exhibitedmore inhibitory effects on collagen production and cellular
migration than the other IOP-lowering drugs. Studies have
revealed that timolol has an inhibitory effect on corneal
epithelial migration [20]. However, timolol has less of an
inhibitory effect than unoprostone on cell proliferation [21]
and less than latanoprost on collagen degradation [13].
These effects may explain the results of the animal study,
wherein timolol had less of an inhibitory effect than uno-
prostone or latanoprost.
360 K.-Y. Wu et al.Although many studies have suggested that therapy with
topical IOP-lowering drugs may enhance the inflammatory
cells and fibroblasts in the conjunctival tissues, these
observations were acquired from long-term collections
involving months and years of use [22,23]. Instead of long-
term use, we utilized IOP-lowering drugs over the short
term, during the critical period of wound healing, in order to
prevent the formation of scarring after glaucoma surgery.
Recently, many prostanoids, such as bimatoprost,
latanoprost, travoprost, and unoprostone have been used
as IOP-lowering drugs in the treatment of glaucoma and
ocular hypertension [24]. Based on the clinical data, the
above four drugs exhibited potent IOP-lowering effects
that were at least as effective as beta-blockers [25].
However, this study presents evidence for the divergence
of the four prostanoids in wound-healing modulation. As
of now, the exact mechanism of latanoprost and uno-
prostone in the inhibition of wound healing remains
unclear. It is interesting to note that the effect of uno-
prostone is better than that of latanoprost, whether
tested in vitro or in vivo. Similar studies have revealed
that unoprostone has a more inhibitory effect on cellular
proliferation than latanoprost in cultured conjunctival
cells [26]. However, it may be explained that latanoprost
displays a strong ability to decrease conjunctival collagen
density [13], and it also causes the expression of trans-
forming growth factor-b, which may stimulate cellular
proliferation [27].
Commercial IOP-lowering drugs usually contain BAK as
a preservative. Numerous studies have revealed that the
BAK contained in IOP-lowering drugs, especially at high
concentrations, has an inhibitory effect on the proliferation
of Tenon’s fibroblasts and may be responsible for ocular
toxicities and inflammation with chronic use [10,28].
Despite this, our studies revealed that IOP-lowering drugs
containing high concentrations of BAK were not greatly
involved in the modulation of wound healing.
According to pharmacokinetic studies with local soaking
of drugs under the sclera flap during trabeculectomy, the
half-life of the drug is 18 minutes in the conjunctiva and
19.2 minutes in the sclera [29]. After topical administration
of tritium-labeled latanoprost, about 7.7% of the applied
dose is found in the cornea 15 minutes after drug admin-
istration [30]. Thus, we estimated the effects of various
drugs in cell culture at 1/10, 1/00, and 1/000 diluted
concentrations from an original dosage after 20 minutes’
exposure.
In conclusion, the short-term applications of some
commercial IOP-lowering drugs were introduced in the
present study to suppress the wound-healing process after
trabeculectomy. Although the exact mechanism by which
latanoprost and unoprostone prevent wound healing after
surgery is unknown, both drugs may potentially be used to
substitute for some highly toxic, antineoplastic drugs that
obstruct wound healing after glaucoma filtering surgery
and, thus, increase the success rate.Acknowledgments
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